GSK 3 beta inhibitors (Helmholtz Zentrum Munchen/Ascenion)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGSK 3 beta inhibitors (Helmholtz Zentrum Munchen/Ascenion)
Drug Alias Nameglycogen synthase kinase 3 beta inhibitors (Helmholtz Zentrum Munchen/Ascenion)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 beta inhibitors
TargetsGlycogen synthase kinase-3 beta
Therapy Area/IndicationsEmphysema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHelmholtz Zentrum Muenchen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHelmholtz Zentrum MuenchenAscenion
Active IndicationsN/A
Inactive IndicationsEmphysema

Other Information

ATC CodeN/A
Related LinksN/A